Dynamic contrast‐enhanced MRI of the prostate: An intraindividual assessment of the effect of temporal resolution on qualitative detection and quantitative analysis of histopathologically proven prostate cancer
- 20 September 2016
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 45 (5) , 1464-1475
Abstract
Purpose: To assess the effects of temporal resolution (RT) in dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) on qualitative tumor detection and quantitative pharmacokinetic parameters in prostate cancer.Materials and Methods: This retrospective Institutional Review Board (IRB)‐approved study included 58 men (64 ± 7 years). They underwent 3T prostate MRI showing dominant peripheral zone (PZ) tumors (24 with Gleason ≥ 4 + 3), prior to prostatectomy. Continuously acquired DCE utilizing GRASP (Golden‐angle RAdial Sparse Parallel) was retrospectively reconstructed at RT of 1.4 sec, 3.7 sec, 6.0 sec, 9.7 sec, and 14.9 sec. A reader placed volumes‐of‐interest on dominant tumors and benign PZ, generating quantitative pharmacokinetic parameters (ktrans, ve) at each RT. Two blinded readers assessed each RT for lesion presence, location, conspicuity, and reader confidence on a 5‐point scale. Data were assessed by mixed‐model analysis of variance (ANOVA), generalized estimating equation (GEE), and receiver operating characteristic (ROC) analysis.Results: RT did not affect sensitivity (R1all: 69.0%–72.4%, all Padj = 1.000; R1GS≥4 + 3: 83.3–91.7%, all Padj = 1.000; R2all: 60.3–69.0%, all Padj = 1.000; R2GS≥4 + 3: 58.3%–79.2%, all Padj = 1.000). R1 reported greater conspicuity of GS ≥ 4 + 3 tumors at RT of 1.4 sec vs. 14.9 sec (4.29 ± 1.23 vs. 3.46 ± 1.44; Padj = 0.029). No other tumor conspicuity pairwise comparison reached significance (R1all: 2.98–3.43, all Padj ≥ 0.205; R2all: 2.57–3.19, all Padj ≥ 0.059; R1GS≥4 + 3: 3.46–4.29, all other Padj ≥ 0.156; R2GS≥4 + 3: 2.92–3.71, all Padj ≥ 0.439). There was no effect of RT on reader confidence (R1all: 3.17–3.34, all Padj = 1.000; R2all: 2.83–3.19, all Padj ≥ 0.801; R1GS≥4 + 3: 3.79–4.21, all Padj = 1.000; R2GS≥4 + 3: 3.13–3.79, all Padj = 1.000). ktrans and ve of tumor and benign tissue did not differ across RT (all adjusted P values [Padj] = 1.000). RT did not significantly affect area under the curve (AUC) of Ktrans or ve for differentiating tumor from benign (all Padj = 1.000).Conclusion: Current PI‐RADS recommendations for RT of 10 seconds may be sufficient, with further reduction to the stated PI‐RADS preference of RT ≤ 7 seconds offering no benefit in tumor detection or quantitative analysis.Level of Evidence: 3J. MAGN. RESON. IMAGING 2017;45:1464–1475Keywords
Funding Information
- Joseph and Diane Steinberg Charitable Trust
- Center for Advanced Imaging Innovation and Research (CAI2R, www.cai2r.net) at New York University School of Medicine is supported by NIH/NIBIB (P41 EB017183)
This publication has 45 references indexed in Scilit:
- Prostate Cancer: Comparison of Dynamic Contrast-Enhanced MRI Techniques for Localization of Peripheral Zone TumorAmerican Journal of Roentgenology, 2013
- Transition Zone Prostate Cancer: Detection and Localization with 3-T Multiparametric MR ImagingRadiology, 2013
- Overview of Dynamic Contrast-Enhanced MRI in Prostate Cancer Diagnosis and ManagementAmerican Journal of Roentgenology, 2012
- Diffusion-Weighted and Dynamic Contrast-Enhanced MRI of Prostate Cancer: Correlation of Quantitative MR Parameters With Gleason Score and Tumor AngiogenesisAmerican Journal of Roentgenology, 2011
- Accelerated phase‐contrast cine MRI using k‐t SPARSE‐SENSEMagnetic Resonance in Medicine, 2011
- Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2‐weighted, dynamic contrast‐enhanced and diffusion‐weighted imagingBJU International, 2010
- The influence of temporal resolution in determining pharmacokinetic parameters from DCE-MRI dataMagnetic Resonance in Medicine, 2010
- Combined diffusion‐weighted and dynamic contrast‐enhanced MRI for prostate cancer diagnosis—Correlation with biopsy and histopathologyJournal of Magnetic Resonance Imaging, 2006
- Evidence for shutter‐speed variation in CR bolus‐tracking studies of human pathologyNMR in Biomedicine, 2004
- The control of the false discovery rate in multiple testing under dependencyThe Annals of Statistics, 2001